Evidence map›Paper›PMID 25849208›Full record

Trial reportBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2015

Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.

Amir A Toor, Roy T Sabo, Catherine H Roberts, Bonny L Moore, Salman R Salman, Allison F Scalora, May T Aziz, Ali S Shubar Ali, Charles E Hall, Jeremy Meier and 10 more

Open access · hybridAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Amir A ToorBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia. Electronic address: atoor@mcvh-vcu.edu.
Roy T SaboDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.
Catherine H RobertsBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Bonny L MooreBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Salman R SalmanBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Allison F ScaloraBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
May T AzizDepartment of Pharmacy and Therapeutics, Virginia Commonwealth University, Richmond, Virginia.
Ali S Shubar AliBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Charles E HallBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Jeremy MeierBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Radhika M ThornBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Elaine WangBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Shiyu SongDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.
Kristin MillerDepartment of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Kathryn RizzoDepartment of Pathology, Virginia Commonwealth University, Richmond, Virginia.
William B ClarkBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
John M McCartyBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Harold M ChungBone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Masoud H ManjiliDepartment of Microbiology & Immunology, Virginia Commonwealth University, Richmond, Virginia.
Michael C NealeDepartments of Psychiatry & Human Genetics, Virginia Commonwealth University, Richmond, Virginia.
Virginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
NCI NIH HHS P30 CA016059
6 · The paper itself

Abstract

Systems that evolve over time and follow mathematical laws as they evolve are called dynamical systems. Lymphocyte recovery and clinical outcomes in 41 allograft recipients conditioned using antithymocyte globulin (ATG) and 4.5-Gy total body irradiation were studied to determine if immune reconstitution could be described as a dynamical system. Survival, relapse, and graft-versus-host disease (GVHD) were not significantly different in 2 cohorts of patients receiving different doses of ATG. However, donor-derived CD3(+) cell reconstitution was superior in the lower ATG dose cohort, and there were fewer instances of donor lymphocyte infusion (DLI). Lymphoid recovery was plotted in each individual over time and demonstrated 1 of 3 sigmoid growth patterns: Pattern A (n = 15) had rapid growth with high lymphocyte counts, pattern B (n = 14) had slower growth with intermediate recovery, and pattern C (n = 10) had poor lymphocyte reconstitution. There was a significant association between lymphocyte recovery patterns and both the rate of change of donor-derived CD3(+) at day 30 after stem cell transplantation (SCT) and clinical outcomes. GVHD was observed more frequently with pattern A, relapse and DLI more so with pattern C, with a consequent survival advantage in patients with patterns A and B. We conclude that evaluating immune reconstitution after SCT as a dynamical system may differentiate patients at risk of adverse outcomes and allow early intervention to modulate that risk.

Indexed as

Models, ImmunologicalTransplantation ConditioningAdultAgedAntilymphocyte SerumFemaleGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansImmunosuppressive AgentsLymphocyte TransfusionMaleMiddle AgedNonlinear DynamicsPrognosisAntilymphocyte SerumImmunosuppressive AgentsDynamical systemGraft-versus-host diseaseImmune reconstitutionStem cell transplantT cells

Identifiers

PMID25849208
PMCPMC4836381
OpenAlexW1974230429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.